Ignite Creation Date:
2024-05-06 @ 7:26 PM
Last Modification Date:
2024-10-26 @ 3:07 PM
Study NCT ID:
NCT06018337
Status:
RECRUITING
Last Update Posted:
2024-06-06
First Post:
2023-08-25
Brief Title:
A Study of DB-1303BNT323 vs Investigators Choice Chemotherapy in HER2-Low Hormone Receptor Positive Metastatic Breast Cancer DYNASTY-Breast02
Sponsor:
Organization:
DualityBio Inc
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
532
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE3 |
Observational Models:
Time Perspective List:
Who Masked List: